Dr. Thomas Klaue

Job Title
Chief Executive Officer
Company
Siqens
Country
Germany

Dr. Thomas Klaue has been on the advisory board since 2019 and was appointed CEO of SIQENS GmbH in July 2022. His mission: to develop the company into an international provider of hydrogen infrastructure solutions and off-grid power supply solutions for critical environments.
This task was preceded by around 20 years as CFO and CEO in mostly listed companies in the healthcare/life science and technology sectors. These included positions at Injex Pharma GmbH (Medtech), MK-Kliniken AG (Health Care) and Medigene AG (Biotech-Pharma). As Vice President Business Development at Infineon Technologies AG, he was responsible for corporate venture capital and the global biochip business. Before that, he worked as head of the M&A department at DASA (now Airbus) on the realignment of the aerospace industry into today's European structures.
Before Dr. When Klaue moved into industry, he worked in research. First as a university assistant at the University of Mannheim, later as a scholarship holder from the German Research Foundation as a research fellow at M.I.T. Sloan School of Management in Boston. His research focus was 'Innovation Management' and 'Organizational Changes' in industrial companies. He has a degree as Dipl.-Ing. and a Dr. rer. pole. the universities of Karlsruhe and Mannheim. He also completed management training at Harvard Business School.

May 09, 2025Electrochemical Hydrogen Separation as the Key to De-carbonized Economies

You are using an outdated browser

The website cannot be viewed in this browser. Please open the website in an up-to-date browser such as Edge, Chrome, Firefox, or Safari.